HLL Lifecare Limited (HLL), a Miniratna public sector enterprise under the Ministry of Health and Family Welfare (MoHFW), has paid a dividend of ₹69.53 crore to the Government of India for the financial year 2024–25, reaffirming its strong financial performance and contribution to India’s public
Built on the values of Confidence, Care and Science, KeyCi is rooted in dermatological research and sustainability Iberia Pharmaceuticals, a leading name in skincare, has launched KeyCi, a science-backed skincare brand designed for modern consumers aged 18–45. KeyCi offers high-performance, dermatologically tested products that are vegan,
The World Health Organization (WHO) has issued a stark warning about the rapidly increasing levels of antibiotic resistance (AMR) across the globe, calling it one of the most urgent public health threats of the century. The organization cautioned that misuse and overuse of antibiotics in
The Government of India has announced the launch of the PRIP (Promoting Research and Innovation in Pharma-MedTech) scheme, inviting proposals from industry players, startups, and research organizations for high-impact projects aimed at strengthening India’s pharmaceutical and medical technology ecosystem. The initiative is designed to accelerate
The latest tariff announcement by U.S. President Donald Trump has raised concerns across global markets, with duties on certain patented and branded medicines being raised up to 100 percent. While the move is seen as a sharp escalation in trade measures, industry experts and government
Saurav Ojha, Co-Founder, Iberia Pharmaceuticals Indian skincare has long borrowed its science from European and other Western countries. However, the formulations that work for their genetic makeup, skin type, weather, sun and pollution exposure is vastly different from Indian skin. In the Indian subcontinent we have
Saurav Ojha, Co-Founder, Iberia Pharmaceuticals India’s skincare narrative is changing, that too at a fast pace. Contrary to earlier experiences, customers are now demanding products that can enhance, rather than ‘fix’ their skin. They are gravitating towards companies that are moving away from superficial branding
In a major breakthrough for India’s medical device sector, the government has stepped in to avert a looming healthcare and supply chain crisis The intervention, led by the Department of Pharmaceuticals (DoP) and the Ministry of Steel, comes as a major relief to manufacturers grappling
Built to global quality and sustainability standards, Iberia’s facility is a key unit under ‘Make-In-India’ movement The company has invested around 70 crores in this world class manufacturing and research facility Iberia Pharmaceuticals, a leading name in skincare, is proud to announce its new hi-tech manufacturing and
Ravishankar Gopalakrishnan, Group Chief Operating Officer & Wholetime Director, Medikabazaar penned down: India’s healthcare ecosystem is evolving rapidly, and with it comes an urgent need to modernise the medical logistics infrastructure that supports it. According to a report by Grand View Research, the healthcare supply chain
